Jinfang Zhao
Peking University(CN)Peking University People's Hospital(CN)
Publications by Year
Research Areas
Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Immune Cell Function and Interaction, Nanoparticles: synthesis and applications, T-cell and B-cell Immunology
Most-Cited Works
- → Biochemical Toxicity of Nano-anatase TiO2 Particles in Mice(2008)275 cited
- → Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease(2017)192 cited
- → Endoscopic ultrasonography with fine-needle aspiration for histological diagnosis of solid pancreatic masses: a meta-analysis of diagnostic accuracy studies(2016)159 cited
- → The Acute Liver Injury in Mice Caused by Nano-Anatase TiO2(2009)151 cited
- → Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren's syndrome(2018)121 cited
- → Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial(2021)102 cited
- → Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1‐Dependent Manner in Mice(2018)74 cited
- → Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19(2021)45 cited
- → Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model(2018)45 cited
- → Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer(2022)43 cited